BeiGene reports BRUKINSA’s efficacy edge in CLL study By Investing.com
© Reuters. BASEL, Switzerland - BeiGene (NASDAQ:), Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE (LON:): 688235), a global biotechnology firm, has ...
Monday, December 16, 2024
Tag: BRUKINSAs
RECOMMENDED
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.